权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

ES Cell-Derived Motoneurons from SMA transgenic mice

来自 SMA 转基因小鼠的 ES 细胞衍生的运动神经元

基本信息

批准号：
7368089
负责人：
DOUGLAS A KERR
金额：
$ 35.85万
依托单位：
JOHNS HOPKINS UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
起止时间：
2005-04-01 至 2009-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7368089
关键词：
Aclarubicin Animals Axon Axonal Transport Back Biology Calcium Calpain Cell Culture System Cell Death Cell Nucleus Cell physiology Cells Cessation of life Chimeric Proteins Clinical Coculture Techniques Collaborations Cyclophosphamide/Fluorouracil/Prednisone Cytoplasm Defect Disease ES Cell Line Embryo Exhibits Exons Functional disorder Genetic Transcription Genomics Human Hydroxybutyrates In Vitro Injury Length Localized Messenger RNA Molecular Motor Motor Neurons Mus Muscle Muscle Contraction Muscle Fibers Neuromuscular Junction Nuclear Pathway interactions Patients Pharmaceutical Preparations Phenotype Presynaptic Terminals Process Production Protein Overexpression RNA Splicing Rate Research Personnel SMN2 gene Signal Transduction Site Skeletal Muscle Skeletal system Spinal Spinal Cord Spinal Muscular Atrophy Staging Stem cells Synapses System Testing Transcript Transgenic Mice Transplantation Ubiquitin Zebrafish axonal pathfinding cell type embryonic stem cell in vivo multicatalytic endopeptidase complex programs research study response stem valproate

项目摘要

DESCRIPTION (provided by applicant): We propose a strategy that relies upon the differentiation of embryonic stem (ES) cells to motoneurons in order to define molecular and cellular abnormalities in Spinal Muscular Atrophy (SMA). We have generated ES cell lines from SMA transgenic mice and have shown that these lines undergo axonal degeneration and ultimately cellular death when differentiated into motoneurons in the presence of skeletal muscle. In Specific Aim 1, we will rigorously define the ability of SMA ES cell-derived motoneurons to form functional neuromuscular junctions with co-cultured skeletal muscle. We will also define abnormalities in axonal transport and the activity of axonal- or cell-death pathways. Specific Aim 2 will define the importance of SMA skeletal muscle in the observed motoneuron phenotype by carrying out selected experiments from Specific Aim 1 with SMA skeletal muscle in co-culture with normal ES cell-derived motoneurons and with SMA ES cell-derived motoneurons. Specific Aim 3 will determine the spatial requirements of SMN to rescue the abnormal motoneuron phenotype by transfecting SMN derivatives that differentially localize to the nucleus, cytoplasm and axons. Specific Aim 4 will define the temporal requirements of SMN to rescue the motoneuron phenotype by utilizing pharmacologic therapies that modulate exon-7 inclusion from SMN2 at various stages during differentiation. Specific Aim 5 will define the phenotype of SMA ES cell-derived motoneurons in ovo following transplantation into embryonic chick spinal cord, thereby defining an abnormality of axon extension or pathfinding. This project will identify critical molecular clues to motoneuron dysfunction in SMA and will identify potential strategies to halt or reverse this dysfunction.

描述（由申请人提供）：我们提出一种依赖于胚胎干（ES）细胞向运动神经元分化的策略，以定义脊髓性肌萎缩症（SMA）的分子和细胞异常。我们已经从SMA转基因小鼠中产生了胚胎干细胞系，并表明这些细胞系在骨骼肌存在的情况下分化为运动神经元时发生轴突变性并最终细胞死亡。在Specific Aim 1中，我们将严格定义SMA ES细胞衍生的运动神经元与共培养骨骼肌形成功能性神经肌肉连接的能力。我们还将定义轴突运输异常和轴突或细胞死亡途径的活动。Specific Aim 2将通过从Specific Aim 1中选择SMA骨骼肌与正常ES细胞衍生的运动神经元和SMA ES细胞衍生的运动神经元共培养的实验来确定SMA骨骼肌在观察到的运动神经元表型中的重要性。特异性Aim 3将通过转染不同定位于细胞核、细胞质和轴突的SMN衍生物来确定SMN的空间要求，以挽救异常的运动神经元表型。特异性目标4将定义SMN的时间要求，通过在分化的不同阶段调节SMN2的外显子7包合的药物治疗来挽救运动神经元表型。特异性Aim 5将定义SMA ES细胞衍生的运动神经元在移植到胚胎鸡脊髓后的卵细胞表型，从而定义轴突延伸或寻径异常。该项目将确定SMA中运动神经元功能障碍的关键分子线索，并将确定阻止或逆转这种功能障碍的潜在策略。